How to Assign and Prioritize Severity Ratings for Healthcare Pen Test Findings

Product Pricing
Ready to get started? Book a demo with our team
Talk to an expert

How to Assign and Prioritize Severity Ratings for Healthcare Pen Test Findings

Kevin Henry

Risk Management

May 14, 2026

7 minutes read
Share this article
How to Assign and Prioritize Severity Ratings for Healthcare Pen Test Findings

Assigning Severity Ratings in Healthcare Pen Testing

A practical scoring workflow

  • Confirm the finding and the affected asset. Identify clinical function (EHR, PACS, infusion pump, telehealth gateway) and data sensitivity, especially any Protected Health Information (PHI).
  • Establish a base score using a CVSS Healthcare Adaptation. Assess the Vulnerability Exploitation Vector (network, adjacent, local, physical), attack complexity, required privileges, user interaction, scope, and impacts to confidentiality, integrity, and availability.
  • Perform an Exploitability Analysis. Determine exploit maturity (public PoC, in-the-wild reports), ease of exploitation, required conditions, and likelihood of lateral movement in your environment.
  • Apply healthcare-specific modifiers. Weigh Patient Safety Impact, clinical workflow disruption, PHI volume/sensitivity, device class (regulated medical device vs. IT system), and exposure (internet-facing, vendor access, flat VLANs).
  • Account for compensating controls. Consider segmentation, MFA, allowlists, EDR, monitoring, and response capabilities that measurably reduce likelihood or blast radius.
  • Derive the severity rating and document rationale. Record the metrics, assumptions, and evidence so reviewers can reproduce the decision.

Healthcare-specific modifiers to emphasize

  • Patient Safety Impact: Could exploitation delay diagnostics, alter therapy, suppress alarms, or cause device malfunction? Any credible safety risk typically raises severity at least one level.
  • PHI Exposure: Identify whether direct identifiers or large data sets are at risk, and whether exfiltration is feasible or only hypothetical.
  • Care Delivery Disruption: Consider scheduling, orders, results, medication administration, and downtime procedures.
  • Operational Constraints: Vendor patch dependencies, maintenance windows, and device certification status that may prolong exposure.
  • Propagation Potential: Ability to traverse clinical networks, pivot from biomedical devices, or abuse shared credentials.

Prioritization Factors for Severity Ratings

  • Patient Safety Impact: Risks to clinical effectiveness, timeliness of care, or physical harm outrank purely informational exposures.
  • Exploitability Analysis: Low-complexity, remotely exploitable issues with reliable exploits deserve top priority.
  • Exposure and Reach: Internet-facing systems, externally reachable VPN portals, or assets on flat networks increase urgency.
  • Asset Criticality: Systems essential to diagnosis, therapy, or coordination of care move higher in the queue.
  • PHI Sensitivity and Volume: Larger, more sensitive PHI repositories demand faster remediation, even when exploitation requires some interaction.
  • Compensating Controls: Strong, enforced controls can justify a lower priority; weak or unenforced controls cannot.
  • Prevalence and Blast Radius: A flaw present across many sites or device fleets should be prioritized above a niche issue.
  • Threat Intelligence: Active exploitation, credible targeting, or relevant campaigns immediately elevates priority.
  • Remediation Availability: A high-impact issue with an available patch or configuration fix should move to the front of the line.

Severity Rating Categories

Category definitions

  • Critical: Remotely exploitable with minimal barriers, enables control or data exfiltration at scale, or presents clear Patient Safety Impact. Often internet-exposed or widely reachable.
  • High: Significant compromise possible, but requires some privileges, user interaction, or specific conditions. Still likely to affect PHI or key clinical workflows.
  • Medium: Constrained by multiple prerequisites, limited access, or partial impact. Local-only issues that don’t easily escalate typically fall here.
  • Low: Minor misconfigurations or informational weaknesses with limited practical impact or strong mitigating controls.
  • Informational: No direct risk by itself; useful for hardening and Healthcare Risk Management planning.

Mapping with a CVSS Healthcare Adaptation

  • Base CVSS Critical or High + credible Patient Safety Impact = Critical severity.
  • Base CVSS High without safety concerns but with PHI exposure or broad reach = High severity.
  • Base CVSS Medium + strong compensating controls and no PHI or safety implications = Medium or Low, as justified.

Risk Assessment Process

From finding to decision

  • Intake and de-duplication: Group similar findings, map to assets, and assign owners.
  • Scoring: Establish base metrics, then apply healthcare modifiers to finalize severity.
  • Treatment selection: Remediate, mitigate, transfer, or accept risk with time-bound justification and executive approval.
  • Plan and implement: Define immediate safeguards, durable fixes, validation steps, and rollback plans where clinical impact is possible.
  • Retest and closure: Verify effectiveness, update the risk register, and capture lessons learned for Healthcare Risk Management.

Target remediation timeframes (adapt to your risk appetite)

  • Critical: 24–72 hours for mitigations; full remediation as soon as feasible.
  • High: Within 15 business days or next approved maintenance window.
  • Medium: Within 30–45 days.
  • Low: Within 90 days or during routine hardening cycles.

Reporting and Communication

What an effective report includes

  • Executive summary: Counts by severity, safety flags, PHI exposure overview, and business impact in plain language.
  • Methodology: How you applied the CVSS Healthcare Adaptation and modifiers.
  • Finding details: Evidence (with PHI redacted), affected versions, Vulnerability Exploitation Vector, exploitability notes, and clear reproduction steps.
  • Actionable guidance: Prioritized fixes, compensating controls, rollback and validation steps, and owner assignments.
  • Risk register linkage: IDs, due dates, and status for ongoing tracking.

Communication cadence

  • Immediate notification for Critical findings to security operations, clinical engineering, and service owners.
  • Daily or weekly checkpoints for High and Medium items until risk is reduced.
  • Final readout with remediation evidence and updated severity if conditions change.

Protecting PHI in reporting

  • Use synthetic data in screenshots, minimize identifiers, and store evidence in restricted repositories.
  • Confirm that vendors receiving evidence are under appropriate agreements and follow HIPAA Compliance expectations.

Regulatory and Compliance Considerations

Severity ratings must align with HIPAA Compliance expectations for risk analysis and risk management. Your documentation should show how you evaluated likelihood, impact to PHI, and potential Patient Safety Impact, how you prioritized remediation, and how you validated fixes. Keep auditable records of decisions, especially risk acceptances, and ensure business associate workflows protect PHI throughout testing and remediation.

For regulated medical devices, coordinate with clinical engineering and vendors to avoid invalidating certifications. When patches are constrained, emphasize layered mitigations, monitoring, and compensating controls while tracking residual risk in your register.

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Continuous Review and Update

Make severity a living decision

  • Refresh ratings when new exploits appear, controls change, assets are re-architected, or clinical workflows evolve.
  • Re-baseline high-impact systems after major updates (EHR upgrades, network segmentation projects, device fleet refreshes).
  • Incorporate intel feeds and lessons from incidents to recalibrate Exploitability Analysis and safety weighting.
  • Automate drift detection where possible and require re-approval for any extended risk acceptance.

Summary

To master how to assign and prioritize severity ratings for healthcare pen test findings, combine a consistent CVSS Healthcare Adaptation with explicit weighting for Patient Safety Impact, PHI exposure, exploitability, and blast radius. Tie decisions to clear remediation timeframes, document rigorously for HIPAA Compliance, communicate swiftly, and keep ratings current as conditions shift.

FAQs.

How do you determine the severity of healthcare pen test findings?

You start with a base CVSS score, then apply healthcare modifiers: Patient Safety Impact, PHI sensitivity and volume, asset criticality, exposure, and the results of your Exploitability Analysis. Compensating controls and operational constraints adjust the final rating, and all assumptions are documented.

What factors prioritize vulnerabilities in healthcare security?

Top drivers are patient safety risk, ease of exploitation and the Vulnerability Exploitation Vector, internet or third-party exposure, clinical criticality of the asset, PHI volume, prevalence across the fleet, threat activity, and availability of a safe, effective fix.

How does HIPAA influence severity ratings?

HIPAA requires risk analysis and risk management. Severity ratings should therefore reflect likelihood and impact to PHI and care delivery, be backed by evidence, and feed into documented remediation or risk acceptance decisions that can withstand audit.

How often should severity ratings be updated?

Update whenever conditions change—new exploits, new controls, architecture shifts, or clinical workflow changes—and at least during each remediation cycle or pen test retest. Critical and High items should be reviewed continuously until risk is demonstrably reduced.

Share this article

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Related Articles